To be distinguished from aneurysm of an aortic sinus (Valsalva) is the rare condition in which an abnormal channel begins in the ascending aorta (above the right coronary artery), bypasses the aortic ...

Medtronic released positive two-year trial Evolut TAVR results that demonstrated superior valve performance in small aortic ...

The data raise questions about valve hemodynamics and the role of early imaging to stay ahead of clinical and subclinical ...

Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally. Researchers at Mayo Clinic are exploring the use of a new drug called ...

Patients at Baylor Medicine, the primary multidisciplinary clinical practice of Baylor College of Medicine, and Baylor St.

Medtronic plc released positive results from a two-year trial of Evolut TAVR that demonstrated superior valve performance in patients with small aortic annuli. The SMall Annuli Randomized To Evolut or ...

The following is a summary of "Tissue-tracking mitral annular displacement predicts impaired left ventricular mechanics and ...

Background: There are insufficient data regarding how to deal with moderate aortic valve (AV) dysfunction during rheumatic mitral valve (MV) surgery. In this study, the clinical outcomes of patients ...

More than 1 in 50 people in this country have an unruptured brain aneurysm. Every 18 minutes, one of those aneurysms will rupture, often leading to death or permanent neurological damage.

Audio Research’s self-declared "finest-ever power amplifier" is now shipping worldwide and it is the culmination of 55 years at the very cutting edge of valve amp design. What you're looking at ...